Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study-Reference-Cited by-同舟云学术

Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study

Published:2013-06-19 Issue:9 Volume:28 Page:2260-2268
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrology Dialysis Transplantation

Author:

Coyne D. W.,Andress D. L.,Amdahl M. J.,Ritz E.,de Zeeuw D.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/28/9/2260/6880645/gft227.pdf

Reference39 articles.

1. Use of vitamin D in chronic kidney disease patients

2. Dismal long‐term survival of dialysis patients after acute myocardial infarction: can we alter the outcome?

3. Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease

4. Outcomes Associated with Serum Calcium Level in Men with Non-Dialysis-Dependent Chronic Kidney Disease

5. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Vitamin D Supplementation in Diabetic Kidney Disease: A Systematic Review;Journal of Renal Nutrition;2023-09

2. Paricalcitol and Extended-Release Calcifediol for Treatment of Secondary Hyperparathyroidism in Non-Dialysis Chronic Kidney Disease: Results From a Network Meta-Analysis;The Journal of Clinical Endocrinology & Metabolism;2023-05-26

3. Influence of type 2 diabetes microangiopathy on bone mineral density and bone metabolism: A meta-analysis;Heliyon;2022-10

4. Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism;PLOS ONE;2022-02-17

5. Vitamin D in kidney disease;Nutritional Management of Renal Disease;2022